Company Reply to “Unexpected Outbreak of Epstein-Barr Virus Post-Transplantation Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplantation Conditioning With Thymoglobulin”
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2014.11.684
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2015
Authors
Publisher
Elsevier BV